Tech-based cancer company raises access concernsOctober 12, 2018Practice ManagementPatient & Survivor CareBreast CancerGynecologic Cancer
Epacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
Dramatic response from pembrolizumab in patient with Lynch syndromeSeptember 24, 2018Immuno-oncologyGynecologic CancerGastroenterologyGastrointestinal Cancer
Pruritus linked to wide variety of cancersSeptember 16, 2018Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic Cancer
VEGF inhibitor shows promise in platinum resistant/refractory ovarian cancerAugust 9, 2018Gynecologic Cancer
Phase 2 trial: Dendritic cell vaccine maintenance prolongs PFS in EOCJuly 30, 2018Gynecologic CancerImmuno-oncology
PARP inhibitors didn’t impair QOL as ovarian cancer maintenance therapyJuly 20, 2018Gynecologic CancerPatient & Survivor Care
ACA coverage mandate leads to more insurance for young women, early gynecologic cancer diagnosesJuly 17, 2018Preventive CareGynecologic Cancer
Intensive nonaspirin NSAID use linked to reduced ovarian cancer mortalityJuly 10, 2018Gynecologic Cancer
